Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 104
Titolo Tipologia Data di pubblicazione Autori File
Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan 01 - Articolo su rivista 2023 Pieruzzi F. +
Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study 01 - Articolo su rivista 2023 Pieruzzi F. +
Erratum: Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy (Clinical Kidney Journal (2022) 15:4 (839) DOI: 10.1093/ckj/sfab148) 99 - Altro 2022 Salerno F. R.Roggero L.Binaggia A.Pieruzzi F. +
An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease 01 - Articolo su rivista 2022 Pieruzzi F. +
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 01 - Articolo su rivista 2022 Moroni, FrancescoPieruzzi, Federico +
α-Gal A missense variants associated with Fabry disease can lead to ER stress and induction of the unfolded protein response 01 - Articolo su rivista 2022 Pieruzzi F. +
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 01 - Articolo su rivista 2022 Lacetera R.Roggero L.Vercelloni P.Uzzo M.Carbone M.Invernizzi P.L'Imperio V.Pieruzzi F.Sinico R. A.
Relapsing minimal change disease superimposed on late-onset p.N215S Fabry nephropathy 01 - Articolo su rivista 2022 Pieruzzi F. +
Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study 01 - Articolo su rivista 2022 Pieruzzi F. +
Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease 01 - Articolo su rivista 2022 Grassi, GuidoFowler, BiancaScali, BeatriceMotto, ElenaPieruzzi, FedericoMancia, Giuseppe +
Correction to: Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (Journal of Nephrology, (2020), 10.1007/s40620-020-00774-5) 99 - Altro 2021 Genovesi S.Pieruzzi F.Contaldo G.Rebora P.Valsecchi M. +
Migalastat treatment in a kidney-transplanted patient with fabry disease and n215s mutation: The first case report 01 - Articolo su rivista 2021 Pieruzzi F. +
Proteomics for the study of new biomarkers in Fabry disease: State of the art 01 - Articolo su rivista 2021 Rossi F.L'Imperio V.Smith A.Bolognesi M. M.Magni F.Pagni F.Pieruzzi F. +
A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease 01 - Articolo su rivista 2021 Pieruzzi, Federico +
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 01 - Articolo su rivista 2021 Genovesi S.Pieruzzi F.Contaldo G.Rebora P.Valsecchi M. +
Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders 01 - Articolo su rivista 2021 Pieruzzi, Federico +
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 01 - Articolo su rivista 2021 Gasperini S.Trezzi B.Pieruzzi F. +
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey 01 - Articolo su rivista 2021 Galione M. A.Pieruzzi F. +
A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients 01 - Articolo su rivista 2021 Pieruzzi F. +
SARS-CoV-2 and Hemodialysis: diffusion and mortality in patients and health care team. Reflections from the Lombardy experience 01 - Articolo su rivista 2021 Pieruzzi, Federico +
Mostrati risultati da 1 a 20 di 104
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile